title: Cognitive-behavioral therapy of insomnia: a clinical case series study of patients with co-morbid disorders and using hypnotic medications.
abstract: Cognitive-behavioral therapy for insomnia (CBTi) has demonstrated considerable efficacy within randomized clinical trials and case-series designs. This case-series study in a community sleep medicine clinic assessed the effectiveness of an eight-session CBTi protocol chronic insomnia patients who were allowed to continue their use of hypnotics (intent-to-treat n = 48), administered by a clinical psychology doctoral student receiving training and supervision in CBTi by a behavioral sleep medicine certified clinician. Outcome measures included daily sleep diaries, self-report measures on insomnia severity, dysfunctional beliefs and attitudes about sleep, daytime sleepiness, as well as medication usage. Patients showed significant improvements in sleep onset latency, wake time after sleep onset, sleep efficiency, insomnia severity, and dysfunctional sleep beliefs from pre- to post-treatment. No changes were seen in daytime sleepiness - patients were not excessively sleepy either before or after treatment. Use of sleep medication declined significantly from 87.5% pre-treatment to 54% post-treatment, despite no active efforts to encourage patients to withdraw. Results demonstrate that a CBTi conducted in a community sleep medicine clinic with patients not required to discontinue sleep-related medications can have similar effects as therapy delivered among those not on medication.
authors.affiliation: Department of Psychology, University of North Texas, Denton, TX 76203-5017, USA. DianaCDolan@gmail.com
authors.forename: Diana C
authors.initials: DC
authors.lastname: Dolan
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Taylor
authors.forename: Adam D
authors.initials: AD
authors.lastname: Bramoweth
authors.forename: Leon D
authors.initials: LD
authors.lastname: Rosenthal
mesh_terms: D000328:Adult; D001294:Attitude to Health; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003153:Community Health Services / Q000379:methods; D015897:Comorbidity; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008499:Medical Records; D012720:Severity of Illness Index; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000628:therapy*; D016896:Treatment Outcome; D014851:Wakefulness / Q000187:drug effects
chemical_list: D006993:Hypnotics and Sedatives